FOXD1 and neuroblastoma: Survival analysis revealed that NB patients with high CAMTA2 protein levels had significantly better OS than NB patients with low CAMTA2 protein levels, while this difference was also observed between high and low FOXD1 groups, without significance (Fig. 11H).